Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency

BACKGROUND & AIMS: The truncating mutations in tight junction protein 2 (TJP2) cause progressive cholestasis, liver failure, and hepatocyte carcinogenesis. Due to the lack of effective model systems, there are no targeted medications for the liver pathology with TJP2 deficiency. We leveraged the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chao Zheng, Ogawa, Hiromi, Ng, Soon Seng, Chen, Xindi, Kishimoto, Eriko, Sakabe, Kokoro, Fukami, Aiko, Hu, Yueh-Chiang, Mayhew, Christopher N., Hellmann, Jennifer, Miethke, Alexander, Tasnova, Nahrin L., Blackford, Samuel J.I., Tang, Zu Ming, Syanda, Adam M., Ma, Liang, Xiao, Fang, Sambrotta, Melissa, Tavabie, Oliver, Soares, Filipa, Baker, Oliver, Danovi, Davide, Hayashi, Hisamitsu, Thompson, Richard J., Rashid, S. Tamir, Asai, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904612/
https://www.ncbi.nlm.nih.gov/pubmed/35284810
http://dx.doi.org/10.1016/j.jhepr.2022.100446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904612/
https://www.ncbi.nlm.nih.gov/pubmed/35284810
http://dx.doi.org/10.1016/j.jhepr.2022.100446

Ejemplares similares